TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)
CUSIP: 89854M101
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Voting Common Stock, par value $0.0001 per share
- Shares outstanding
- 52,382,313
- Total 13F shares
- 9,861,945
- Share change
- -272,994
- Total reported value
- $44,380,000
- Price per share
- $4.50
- Number of holders
- 28
- Value change
- -$2,457,435
- Number of buys
- 11
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 89854M101?
CUSIP 89854M101 identifies TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89854M101:
Top shareholders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
1,500,577
|
$12,515,000 | — | 30 Sep 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.7%
|
1,425,000
|
$11,885,000 | — | 30 Sep 2021 | |
| Christoph H. Westphal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,193,472
|
$10,898,266 | — | 20 Jul 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.4%
|
1,282,976
|
$10,700,000 | — | 30 Sep 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.4%
|
1,255,317
|
$10,469,000 | — | 30 Sep 2021 | |
| Deer IX & Co. Ltd. |
13F
|
Company |
2.4%
|
1,245,505
|
$9,349,000 | — | 30 Sep 2021 | |
| Alphabet Inc. |
13F
|
Company |
2.1%
|
1,077,080
|
$8,983,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.95%
|
496,583
|
$4,142,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.85%
|
444,894
|
$3,710,000 | — | 30 Sep 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.38%
|
200,000
|
$1,668,000 | — | 30 Sep 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.27%
|
139,566
|
$1,163,000 | — | 30 Sep 2021 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.19%
|
100,000
|
$834,000 | — | 30 Sep 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.14%
|
75,000
|
$626,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.11%
|
60,000
|
$500,000 | — | 30 Sep 2021 | |
| DC Investments Management, LLC |
13F
|
Company |
0.07%
|
35,563
|
$297,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
30,240
|
$252,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
28,236
|
$235,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
22,817
|
$190,000 | — | 30 Sep 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.04%
|
22,200
|
$185,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
13,000
|
$108,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
12,786
|
$106,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
12,200
|
$102,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
11,922
|
$99,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
11,531
|
$96,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,000
|
$8,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
946
|
$8,000 | — | 30 Sep 2021 | |
| DC Funds, LP |
13F
|
Company |
1.2%
|
630,000
|
$5,254 | — | 30 Sep 2021 |
Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q4 2021
As of 31 Dec 2021,
TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,861,945 shares.
The largest 10 holders included
BlackRock Inc., BAKER BROS. ADVISORS LP, HHLR ADVISORS, LTD., RA CAPITAL MANAGEMENT, L.P., Deer Management Co. LLC, Alphabet Inc., DC Funds, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, and Tekla Capital Management LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
25
Q4 2021 holders
28
Holder diff
3
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.